BW

Brad Ward

Director Of Research & Development at Pharma Tech Industries

Brad Ward has extensive work experience in the pharmaceutical industry. Brad most recently served as the Director of Research & Development at Pharma Tech Industries starting in April 2023. Prior to that, they worked as the Associate Director of Formulation Development at the same company from January 2022 to April 2023. Before joining Pharma Tech Industries, Brad worked at SPI Pharma as a Formulation/Process Design Scientist from June 2016 to January 2022. Brad also worked at Perrigo Company plc as a Formulation Technician from August 2014 to June 2016 and as a Compression Specialist from January 2014 to August 2014. Brad began their career in the United States Air Force, serving as a Security Forces officer from August 2002 to August 2006.

Brad Ward obtained a Bachelor's of Science degree with a concentration in Mathematics, Chemistry, and Physics from Western Michigan University from 2010 to 2015. Prior to that, they earned an Associate of Science (A.S.) degree in Electrical and Electronics Engineering from Kalamazoo Valley Community College from 2007 to 2012. Additionally, they completed an Associate of Arts (A.A.) degree in Accounting and Business/Management from the same institution during the same time period. In terms of certifications, Brad obtained various certifications from LinkedIn, including "Becoming an Impactful and Influential Leader," "Jeff Weiner on Establishing a Culture and a Plan for Scaling," "Jeff Weiner on Leading like a CEO," "Communication within Teams," "Developing Executive Presence," "Executive Decision-Making," "Executive Leadership," "Be the Manager People Won't Leave," "Persuading Others," "Agile Project Management with Microsoft Project," "Communicating to Drive People to Take Action," "How to Handle Poor Performers," "Six Sigma: Black Belt," "Six Sigma: Green Belt," and "Transitioning from Manager to Leader" from 2021 to 2022.

Links

Previous companies

Perrigo logo

Timeline

  • Director Of Research & Development

    April, 2023 - present

  • Associate Director Of Formulation Development

    January, 2022